Monday, September 27, 2010 12:02:39 PM
Sep 27, 2010 (SmarTrend News Watch via COMTEX) -- In a unanimous 13-0 vote, the
FDA said that Hologic's (NASDAQ:HOLX) 3D mammography device is safe and
effective noting that the benefits of this new device outweigh the risks. The
company believes that its new Selenia Dimensions 3D device is a new method for
screening and diagnosing breast cancer that, when used with conventional 2D
methods, can improve overall cancer detection rates.
Co-Founder and CTO Jay Stein said, "The system is designed to increase accuracy
when screening women for the presence of cancerous tissue, and to enable a more
precise characterization of suspicious lesions. I speak for all of Hologic in
voicing great satisfaction that the FDA Panel has weighed in so positively in
favor of this valuable new tool in the battle to limit breast cancer mortality."
SmarTrend currently has Hologic in an Uptrend. Since 2008, SmarTrend subscribers
trading Hologic using our alerts outperformed the stock by 117%. We are
monitoring these developments and will alert subscribers to any change in trend.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM